nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftizoxime—Cellulitis—Vandetanib—thyroid cancer	0.0481	0.0481	CcSEcCtD
Ceftizoxime—Prothrombin level increased—Epirubicin—thyroid cancer	0.0266	0.0266	CcSEcCtD
Ceftizoxime—Neutropenia—Vandetanib—thyroid cancer	0.0257	0.0257	CcSEcCtD
Ceftizoxime—Prothrombin level increased—Doxorubicin—thyroid cancer	0.0246	0.0246	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.0243	0.0243	CcSEcCtD
Ceftizoxime—Haemoglobin—Vandetanib—thyroid cancer	0.0221	0.0221	CcSEcCtD
Ceftizoxime—Haemorrhage—Vandetanib—thyroid cancer	0.022	0.022	CcSEcCtD
Ceftizoxime—Lactic dehydrogenase activity increased—Epirubicin—thyroid cancer	0.0213	0.0213	CcSEcCtD
Ceftizoxime—Erythema multiforme—Vandetanib—thyroid cancer	0.0208	0.0208	CcSEcCtD
Ceftizoxime—Lactic dehydrogenase activity increased—Doxorubicin—thyroid cancer	0.0197	0.0197	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.0193	0.0193	CcSEcCtD
Ceftizoxime—Blood lactate dehydrogenase increased—Epirubicin—thyroid cancer	0.0188	0.0188	CcSEcCtD
Ceftizoxime—Thrombocytosis—Epirubicin—thyroid cancer	0.0175	0.0175	CcSEcCtD
Ceftizoxime—Blood lactate dehydrogenase increased—Doxorubicin—thyroid cancer	0.0174	0.0174	CcSEcCtD
Ceftizoxime—Neutropenia—Sorafenib—thyroid cancer	0.0173	0.0173	CcSEcCtD
Ceftizoxime—Convulsion—Vandetanib—thyroid cancer	0.0166	0.0166	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.0164	0.0164	CcSEcCtD
Ceftizoxime—Thrombocytosis—Doxorubicin—thyroid cancer	0.0162	0.0162	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Vandetanib—thyroid cancer	0.0153	0.0153	CcSEcCtD
Ceftizoxime—Haemoglobin—Sorafenib—thyroid cancer	0.0149	0.0149	CcSEcCtD
Ceftizoxime—Haemorrhage—Sorafenib—thyroid cancer	0.0148	0.0148	CcSEcCtD
Ceftizoxime—Paraesthesia—Vandetanib—thyroid cancer	0.014	0.014	CcSEcCtD
Ceftizoxime—Erythema multiforme—Sorafenib—thyroid cancer	0.014	0.014	CcSEcCtD
Ceftizoxime—Injection site pain—Epirubicin—thyroid cancer	0.0134	0.0134	CcSEcCtD
Ceftizoxime—Pain—Vandetanib—thyroid cancer	0.0133	0.0133	CcSEcCtD
Ceftizoxime—Injection site pain—Doxorubicin—thyroid cancer	0.0124	0.0124	CcSEcCtD
Ceftizoxime—Body temperature increased—Vandetanib—thyroid cancer	0.0123	0.0123	CcSEcCtD
Ceftizoxime—Cellulitis—Epirubicin—thyroid cancer	0.012	0.012	CcSEcCtD
Ceftizoxime—Anaemia—Sorafenib—thyroid cancer	0.0119	0.0119	CcSEcCtD
Ceftizoxime—Leukopenia—Sorafenib—thyroid cancer	0.0115	0.0115	CcSEcCtD
Ceftizoxime—Cellulitis—Doxorubicin—thyroid cancer	0.0111	0.0111	CcSEcCtD
Ceftizoxime—Pruritus—Vandetanib—thyroid cancer	0.011	0.011	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Epirubicin—thyroid cancer	0.0109	0.0109	CcSEcCtD
Ceftizoxime—Diarrhoea—Vandetanib—thyroid cancer	0.0107	0.0107	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Sorafenib—thyroid cancer	0.0105	0.0105	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Sorafenib—thyroid cancer	0.0103	0.0103	CcSEcCtD
Ceftizoxime—Vaginal infection—Epirubicin—thyroid cancer	0.0103	0.0103	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Epirubicin—thyroid cancer	0.0102	0.0102	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Doxorubicin—thyroid cancer	0.0101	0.0101	CcSEcCtD
Ceftizoxime—Vomiting—Vandetanib—thyroid cancer	0.00992	0.00992	CcSEcCtD
Ceftizoxime—Rash—Vandetanib—thyroid cancer	0.00984	0.00984	CcSEcCtD
Ceftizoxime—Dermatitis—Vandetanib—thyroid cancer	0.00983	0.00983	CcSEcCtD
Ceftizoxime—Vaginal infection—Doxorubicin—thyroid cancer	0.00953	0.00953	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Doxorubicin—thyroid cancer	0.00947	0.00947	CcSEcCtD
Ceftizoxime—Nausea—Vandetanib—thyroid cancer	0.00927	0.00927	CcSEcCtD
Ceftizoxime—Phlebitis—Epirubicin—thyroid cancer	0.00919	0.00919	CcSEcCtD
Ceftizoxime—Pain—Sorafenib—thyroid cancer	0.009	0.009	CcSEcCtD
Ceftizoxime—Phlebitis—Doxorubicin—thyroid cancer	0.0085	0.0085	CcSEcCtD
Ceftizoxime—Body temperature increased—Sorafenib—thyroid cancer	0.00832	0.00832	CcSEcCtD
Ceftizoxime—Hypersensitivity—Sorafenib—thyroid cancer	0.00776	0.00776	CcSEcCtD
Ceftizoxime—Pruritus—Sorafenib—thyroid cancer	0.00745	0.00745	CcSEcCtD
Ceftizoxime—Diarrhoea—Sorafenib—thyroid cancer	0.0072	0.0072	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00713	0.00713	CcSEcCtD
Ceftizoxime—Eosinophilia—Epirubicin—thyroid cancer	0.00677	0.00677	CcSEcCtD
Ceftizoxime—Vomiting—Sorafenib—thyroid cancer	0.00669	0.00669	CcSEcCtD
Ceftizoxime—Rash—Sorafenib—thyroid cancer	0.00664	0.00664	CcSEcCtD
Ceftizoxime—Dermatitis—Sorafenib—thyroid cancer	0.00663	0.00663	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.0066	0.0066	CcSEcCtD
Ceftizoxime—Pancytopenia—Epirubicin—thyroid cancer	0.0065	0.0065	CcSEcCtD
Ceftizoxime—Neutropenia—Epirubicin—thyroid cancer	0.0064	0.0064	CcSEcCtD
Ceftizoxime—Eosinophilia—Doxorubicin—thyroid cancer	0.00627	0.00627	CcSEcCtD
Ceftizoxime—Nausea—Sorafenib—thyroid cancer	0.00625	0.00625	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00605	0.00605	CcSEcCtD
Ceftizoxime—Pancytopenia—Doxorubicin—thyroid cancer	0.00601	0.00601	CcSEcCtD
Ceftizoxime—Neutropenia—Doxorubicin—thyroid cancer	0.00592	0.00592	CcSEcCtD
Ceftizoxime—Agranulocytosis—Epirubicin—thyroid cancer	0.00569	0.00569	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.0056	0.0056	CcSEcCtD
Ceftizoxime—Haemoglobin—Epirubicin—thyroid cancer	0.0055	0.0055	CcSEcCtD
Ceftizoxime—Haemorrhage—Epirubicin—thyroid cancer	0.00548	0.00548	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Epirubicin—thyroid cancer	0.00545	0.00545	CcSEcCtD
Ceftizoxime—Agranulocytosis—Doxorubicin—thyroid cancer	0.00527	0.00527	CcSEcCtD
Ceftizoxime—Erythema multiforme—Epirubicin—thyroid cancer	0.00518	0.00518	CcSEcCtD
Ceftizoxime—Haemoglobin—Doxorubicin—thyroid cancer	0.00509	0.00509	CcSEcCtD
Ceftizoxime—Haemorrhage—Doxorubicin—thyroid cancer	0.00507	0.00507	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00504	0.00504	CcSEcCtD
Ceftizoxime—Erythema multiforme—Doxorubicin—thyroid cancer	0.00479	0.00479	CcSEcCtD
Ceftizoxime—Anaemia—Epirubicin—thyroid cancer	0.00441	0.00441	CcSEcCtD
Ceftizoxime—Leukopenia—Epirubicin—thyroid cancer	0.00427	0.00427	CcSEcCtD
Ceftizoxime—Convulsion—Epirubicin—thyroid cancer	0.00413	0.00413	CcSEcCtD
Ceftizoxime—Anaemia—Doxorubicin—thyroid cancer	0.00408	0.00408	CcSEcCtD
Ceftizoxime—Leukopenia—Doxorubicin—thyroid cancer	0.00395	0.00395	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Epirubicin—thyroid cancer	0.00389	0.00389	CcSEcCtD
Ceftizoxime—Convulsion—Doxorubicin—thyroid cancer	0.00382	0.00382	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Epirubicin—thyroid cancer	0.00381	0.00381	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Doxorubicin—thyroid cancer	0.0036	0.0036	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00352	0.00352	CcSEcCtD
Ceftizoxime—Paraesthesia—Epirubicin—thyroid cancer	0.00349	0.00349	CcSEcCtD
Ceftizoxime—Pain—Epirubicin—thyroid cancer	0.00333	0.00333	CcSEcCtD
Ceftizoxime—Paraesthesia—Doxorubicin—thyroid cancer	0.00323	0.00323	CcSEcCtD
Ceftizoxime—Pain—Doxorubicin—thyroid cancer	0.00308	0.00308	CcSEcCtD
Ceftizoxime—Body temperature increased—Epirubicin—thyroid cancer	0.00308	0.00308	CcSEcCtD
Ceftizoxime—Hypersensitivity—Epirubicin—thyroid cancer	0.00287	0.00287	CcSEcCtD
Ceftizoxime—Body temperature increased—Doxorubicin—thyroid cancer	0.00285	0.00285	CcSEcCtD
Ceftizoxime—Pruritus—Epirubicin—thyroid cancer	0.00275	0.00275	CcSEcCtD
Ceftizoxime—Diarrhoea—Epirubicin—thyroid cancer	0.00266	0.00266	CcSEcCtD
Ceftizoxime—Hypersensitivity—Doxorubicin—thyroid cancer	0.00265	0.00265	CcSEcCtD
Ceftizoxime—Pruritus—Doxorubicin—thyroid cancer	0.00255	0.00255	CcSEcCtD
Ceftizoxime—Vomiting—Epirubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Ceftizoxime—Diarrhoea—Doxorubicin—thyroid cancer	0.00246	0.00246	CcSEcCtD
Ceftizoxime—Rash—Epirubicin—thyroid cancer	0.00245	0.00245	CcSEcCtD
Ceftizoxime—Dermatitis—Epirubicin—thyroid cancer	0.00245	0.00245	CcSEcCtD
Ceftizoxime—Nausea—Epirubicin—thyroid cancer	0.00231	0.00231	CcSEcCtD
Ceftizoxime—Vomiting—Doxorubicin—thyroid cancer	0.00229	0.00229	CcSEcCtD
Ceftizoxime—Rash—Doxorubicin—thyroid cancer	0.00227	0.00227	CcSEcCtD
Ceftizoxime—Dermatitis—Doxorubicin—thyroid cancer	0.00227	0.00227	CcSEcCtD
Ceftizoxime—Nausea—Doxorubicin—thyroid cancer	0.00214	0.00214	CcSEcCtD
